The SAGE Working Group on Vaccine Hesitancy developed a vaccine hesitancy measure, the Vaccine Hesitancy Scale (VHS). This scale has the potential to aid in the advancement of research and immunization policy but has not yet been psychometrically evaluated.
This blog explains that health professionals need to approach their patients who are opposed to vaccination with understanding and patience.
Although it is only possible to recognize resilience retrospectively, the COVID-19 pandemic has occurred at a point in human history when, uniquely, sufficient knowledge is available on the early-life determinants of health to indicate clearly that a focus on maternal, neonatal, and child health (MNCH) will promote later resilience.
This website, which is updated regularly, is dedicated to debunking common Covid skeptic arguments, and highlighting the track record of some of the most influential and consistently-wrong skeptics. It mostly focuses on UK-based skeptics.
“Long covid” is a term being used to describe illness in people who have either recovered from covid-19 but are still report lasting effects of the infection or have had the usual symptoms for far longer than would be expected. Many people, including doctors who have been infected, have shared their anecdotal experiences on social media, in the traditional media, and through patients’ groups.
Research has shown that it is not enough to provide information on vaccines to encourage their uptake. The WHO Technical Advisory Group (TAG) on Behavioural Insights and Sciences for Health has published a report outlining the factors that drive people’s behaviour when it comes to vaccines: an enabling environment, social influences, and motivation.
On April 9, 2020, the World Health Organization (WHO) Global Malaria Program (GMP) released guidance, Tailoring Malaria Interventions in the COVID19 Response, to address malaria within the context of COVID-19.
This paper makes the case for immediate planning for a COVID-19 vaccination uptake strategy in advance of vaccine availability for two reasons: first, the need to build a consensus about the order in which groups of the population will get access to the vaccine; second, to reduce any fear and concerns that exist in relation to vaccination and to create demand for vaccines. A key part of this strategy is to counter the anti-vaccination movement that is already promoting hesitancy and resistance.